Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control

BACKGROUND AND PURPOSE: To minimize cognitive decline without increasing brain tumor recurrence (BTR) by reduced-dose whole-brain radiotherapy (RD-WBRT) (25 Gy, 10 fractions) + stereotactic radiosurgery (SRS) in patients with ≤ 4 brain metastases. MATERIALS AND METHODS: Eligible patients with ≤ 4 br...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakano, Toshimichi, Aoyama, Hidefumi, Onodera, Shunsuke, Igaki, Hiroshi, Matsumoto, Yasuo, Kanemoto, Ayae, Shimamoto, Shigetoshi, Matsuo, Masayuki, Tanaka, Hidekazu, Oya, Natsuo, Matsuyama, Tomohiko, Ohta, Atsushi, Maruyama, Katsuya, Tanaka, Takahiro, Kitamura, Nobutaka, Akazawa, Kohei, Maebayashi, Katsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529504/
https://www.ncbi.nlm.nih.gov/pubmed/36199814
http://dx.doi.org/10.1016/j.ctro.2022.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529504/
https://www.ncbi.nlm.nih.gov/pubmed/36199814
http://dx.doi.org/10.1016/j.ctro.2022.09.005

Ejemplares similares